UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 315

Sortiert nach

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study

Scientific reports, 2024-06, Vol.14 (1), p.12872-12

2024

Volltextzugriff (PDF)

Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis

Clinical and experimental allergy, 2011-04, Vol.41 (4), p.565-573

2011

Volltextzugriff (PDF)

Vaccine Potentials of an Intrinsically Unstructured Fragment Derived from the Blood Stage-Associated Plasmodium falciparum Protein PFF0165c

Infection and Immunity, 2009-12, Vol.77 (12), p.5701-5709

2009

Volltextzugriff (PDF)

Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

Infection and Immunity, 2005-12, Vol.73 (12), p.8017-8026

2005

Volltextzugriff (PDF)

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

Vaccine, 2003-03, Vol.21 (11), p.1250-1255

2003

Volltextzugriff (PDF)

Supplemental parenteral nutrition does not alter carbohydrate and protein metabolism and improves immunity: The SPN2 randomized trial

Clinical nutrition (Edinburgh, Scotland), 2018-09, Vol.37, p.S169-S169

2018

Volltextzugriff (PDF)

A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum

PLoS medicine, 2005-11, Vol.2 (11), p.e344-e344

2005

Volltextzugriff (PDF)

A synthetic malaria vaccine elicits a potent CD8+ and CD4+ T lymphocyte immune response in humans. Implications for vaccination strategies

European journal of immunology, 2001-07, Vol.31 (7), p.1989-1998

2001

Volltextzugriff (PDF)

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

Vaccine, 1999-03, Vol.17 (9), p.1047-1056

1999

Volltextzugriff (PDF)

Improving stability and release kinetics of microencapsulated tetanus toxoid by Co-encapsulation of additives

Pharmaceutical research, 1998-07, Vol.15 (7), p.1103-1110

1998

Volltextzugriff (PDF)

Adhesion molecule expression and response to chemotactic agents of human monocyte‐derived macrophages

Clinical and experimental immunology, 1996-01, Vol.103 (1), p.155-160

1996

Volltextzugriff (PDF)

Interactions between human macrophages and tumor cells in three-dimensional cultures

Cancer Immunology Immunotherapy, 1994-09, Vol.39 (5), p.299-304

1994

Volltextzugriff (PDF)

Trastuzumab versus MYL-1401O (a proposed trastuzumab biosimilar) in a phase I bioequivalence study: In vivo and in vitro immunomodulation

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.10-10

2017

Volltextzugriff (PDF)

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

Vaccine, 1997-08, Vol.15 (12), p.1405-1412

1997

Volltextzugriff (PDF)

Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions

Journal of controlled release, 2004-10, Vol.99 (3), p.345-355

2004

Volltextzugriff (PDF)

OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242–310 from the circumsporozoite protein of Plasmodium berghei

Vaccine, 2003-06, Vol.21 (19), p.2485-2491

2003

Volltextzugriff (PDF)

The isolation of IgG from mammalian sera with the aid of caprylic acid

Archives of biochemistry and biophysics, 1969-11, Vol.134 (2), p.279-284

1969

Volltextzugriff (PDF)

Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies

Parassitologia, 1999-09, Vol.41 (1-3), p.421

1999

Volltextzugriff (PDF)

Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents

Pharmaceutical research, 1998-07, Vol.15 (7), p.1111-1116

1998

Volltextzugriff (PDF)

Specific interferon-gamma assays: a modern tool for tuberculosis diagnosis

Revue médicale suisse, 2006-04, Vol.2 (62), p.1042, 1044

2006

Volltextzugriff (PDF)

Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte--macrophage colony-stimulating factor

Journal of immunotherapy, 2000-11, Vol.23 (6), p.675-679

2000

Volltextzugriff (PDF)

Studies on the complement level in relation to the age of guinea pigs and rabbits

Comptes rendus hebdomadaires des séances de l'Académie des sciences, 1960-02, Vol.250, p.949-951

AUDRAN, R

1960

Volltextzugriff (PDF)

728 - Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e1050-e1050

2018

Volltextzugriff (PDF)

Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

European urology supplements : official journal of the European Association of Urology, 2018-03, Vol.17 (2), p.e1050

2018

Volltextzugriff (PDF)

Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously

Nuclear medicine and biology, 1995-08, Vol.22 (6), p.817-821

1995

Volltextzugriff (PDF)

1 – 25 von 315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(249)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(147)
Humans
(111)
Life Sciences & Biomedicine
(79)
Physical Sciences
(71)
Chemistry
(68)
Chemical Sciences
(55)
Biological And Medical Sciences
(43)
Animals
(36)
Female
(35)
Chemistry, Organic
(29)
Medical Sciences
(29)
Male
(25)
Fundamental And Applied Biological Sciences. Psychology
(22)
Old Medline
(22)
Chemistry, Multidisciplinary
(21)
Adult
(19)
Life Sciences
(19)
Aged
(16)
Gamma-Globulins
(16)
Middle Aged
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study

Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis

Vaccine Potentials of an Intrinsically Unstructured Fragment Derived from the Blood Stage-Associated Plasmodium falciparum Protein PFF0165c

Phase I Malaria Vaccine Trial with a Long Synthetic Peptide Derived from the Merozoite Surface Protein 3 Antigen

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

Supplemental parenteral nutrition does not alter carbohydrate and protein metabolism and improves immunity: The SPN2 randomized trial

A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum

A synthetic malaria vaccine elicits a potent CD8+ and CD4+ T lymphocyte immune response in humans. Implications for vaccination strategies

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

Improving stability and release kinetics of microencapsulated tetanus toxoid by Co-encapsulation of additives

Adhesion molecule expression and response to chemotactic agents of human monocyte‐derived macrophages

Interactions between human macrophages and tumor cells in three-dimensional cultures

Trastuzumab versus MYL-1401O (a proposed trastuzumab biosimilar) in a phase I bioequivalence study: In vivo and in vitro immunomodulation

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions

OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242–310 from the circumsporozoite protein of Plasmodium berghei

The isolation of IgG from mammalian sera with the aid of caprylic acid

Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies

Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents

Specific interferon-gamma assays: a modern tool for tuberculosis diagnosis

Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte--macrophage colony-stimulating factor

Studies on the complement level in relation to the age of guinea pigs and rabbits

728 - Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously

Suchergebnisse filtern